{"id":416,"date":"2024-04-25T12:09:17","date_gmt":"2024-04-25T12:09:17","guid":{"rendered":"http:\/\/annualreport-2025.guerillainteractive.co.uk\/?page_id=416"},"modified":"2025-07-24T13:03:40","modified_gmt":"2025-07-24T13:03:40","slug":"activites-antifalsification","status":"publish","type":"page","link":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/fr\/activites-antifalsification\/","title":{"rendered":"Activit\u00e9s antifalsification"},"content":{"rendered":"
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
<\/div>\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Qualit\u00e9 et utilisation des m\u00e9dicaments\n<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Qualit\u00e9 et utilisation des m\u00e9dicaments\n<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Les produits m\u00e9dicaux (m\u00e9dicaments et dispositifs m\u00e9dicaux) falsifi\u00e9s pr\u00e9sentent des risques importants, susceptibles de compromettre l\u2019efficacit\u00e9 des traitements, voire de mettre en danger la vie des personnes soign\u00e9es. Pour parer \u00e0 ces risques et prot\u00e9ger la sant\u00e9 publique, l\u2019EDQM d\u00e9ploie des efforts intenses destin\u00e9s \u00e0 favoriser le dialogue et la coop\u00e9ration \u00e0 l\u2019\u00e9chelle internationale, encourager le partage d\u2019expertise et d\u2019informations, ainsi que d\u00e9velopper des outils, des cadres et des strat\u00e9gies de pr\u00e9vention des risques et de r\u00e9duction des pr\u00e9judices. Ces activit\u00e9s sont principalement du ressort du Comit\u00e9 europ\u00e9en sur les produits et les soins pharmaceutiques (CD-P-PH), du Comit\u00e9 d\u2019Experts sur la r\u00e9duction des risques de sant\u00e9 publique li\u00e9s \u00e0 la falsification de produits m\u00e9dicaux et aux infractions similaires (CD-P-PH\/CMED\u00a0\u2013 comit\u00e9 subordonn\u00e9) et du Groupe de Travail\u00a0OMCL sur les m\u00e9dicaments falsifi\u00e9s. L\u2019EDQM apporte \u00e9galement son soutien \u00e0 la Convention\u00a0MEDICRIME du Conseil de l\u2019Europe<\/a> et \u00e0 son Comit\u00e9 des Parties.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Programme de travail<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

L\u2019adoption de la Recommandation\u00a0CM\/Rec(2024)3 sur la d\u00e9claration des disparitions de m\u00e9dicaments \u00e0 usage humain ou v\u00e9t\u00e9rinaire de la cha\u00eene d\u2019approvisionnement l\u00e9gale<\/a><\/span> par le Comit\u00e9 des Ministres du Conseil de l\u2019Europe a \u00e9t\u00e9 l\u2019un des temps forts de l\u2019ann\u00e9e\u00a02024 pour le CD-P-PH\/CMED. Cette recommandation sensibilise \u00e0 l\u2019importance d\u2019informer les autorit\u00e9s r\u00e9glementaires de sant\u00e9 des disparitions de m\u00e9dicaments. Le projet d\u2019orientations destin\u00e9es \u00e0 aider les autorit\u00e9s \u00e0 mettre en \u0153uvre cette recommandation a, par ailleurs, bien avanc\u00e9.<\/p>

En juin\u00a02024, le 7e<\/sup>\u00a0atelier CMED destin\u00e9 aux inspecteurs et inspectrices BPF\/BPD\/de pharmacie s\u2019est d\u00e9roul\u00e9 \u00e0 Sofia (Bulgarie). Les personnes participantes sont venues de Bulgarie, de G\u00e9orgie, de R\u00e9publique de Moldova et de Roumanie. Le but \u00e9tait de les sensibiliser aux signaux susceptibles d\u2019indiquer une falsification, et ce, de mani\u00e8re interactive et pratique par l\u2019\u00e9tude de cas r\u00e9els.<\/p>

L\u2019\u00e9laboration d\u2019un document d\u2019orientation sur les d\u00e9finitions relatives \u00e0 la lutte contre la falsification des m\u00e9dicaments a largement progress\u00e9 tout au long de l\u2019ann\u00e9e\u00a02024.<\/p>

Les produits fronti\u00e8res (cas dans lesquels il subsiste un doute quant au statut d\u2019un produit donn\u00e9\u00a0: m\u00e9dicament ou autre produit de sant\u00e9) posent des difficult\u00e9s particuli\u00e8res. Le r\u00e9seau de l\u2019EDQM consacr\u00e9 aux produits fronti\u00e8res a apport\u00e9 un soutien \u00e0 ses membres sur les questions relatives \u00e0 la mise en application ou \u00e0 la supervision de la l\u00e9gislation en vigueur dans ce domaine. Il a examin\u00e9 plusieurs cas sous l\u2019\u00e9gide du CD-P-PH, qui est charg\u00e9 de ce r\u00e9seau. Une r\u00e9union pl\u00e9ni\u00e8re a \u00e9t\u00e9 organis\u00e9e en juin\u00a02024, en coop\u00e9ration avec l\u2019Agence bulgare des m\u00e9dicaments, et une r\u00e9union en ligne s\u2019est tenue en novembre.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Communication avec les partenaires et parties int\u00e9ress\u00e9es<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Pour renforcer la coop\u00e9ration, des repr\u00e9sentant\u00b7es de l\u2019EDQM ont pris part, au printemps\u00a02024, \u00e0 la r\u00e9union du groupe de travail du r\u00e9seau\u00a0HMA pour la mise en \u0153uvre de la l\u00e9gislation (HMA-WGEO). L\u2019EDQM a eu l\u2019honneur d\u2019accueillir, \u00e0 Strasbourg, la r\u00e9union pl\u00e9ni\u00e8re d\u2019automne de ce r\u00e9seau, \u00e0 laquelle ont assist\u00e9 81\u00a0personnes venues de 25\u00a0\u00c9tats membres de l\u2019UE et d\u2019ailleurs.<\/p>

Le secr\u00e9tariat et le pr\u00e9sident du CD-P-PH\/CMED de l\u2019EDQM ont particip\u00e9 \u00e0 la r\u00e9union pl\u00e9ni\u00e8re du Comit\u00e9 des Parties\u00a0MEDICRIME et ont travaill\u00e9 activement avec son secr\u00e9tariat \u00e0 l\u2019harmonisation des activit\u00e9s dans ce domaine et dans d\u2019autres dans lesquels le CD-P-PH\/CMED est actif.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Publications, bases de donn\u00e9es et site web<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

La base de donn\u00e9es\u00a0Know-X de l\u2019EDQM contient des informations exhaustives sur des cas sp\u00e9cifiques de falsification de produits m\u00e9dicaux. Elle permet aux Autorit\u00e9s de sant\u00e9 et aux services r\u00e9pressifs de toute l\u2019Europe de partager des informations et de traiter plus rapidement les affaires de produits m\u00e9dicaux suspects (par exemple gr\u00e2ce \u00e0 sa fonction d\u2019alerte rapide, qui permet de signaler de nouvelles affaires en temps r\u00e9el). Le CD-P-PH\/CMED et le Groupe de Travail\u00a0OMCL sur les m\u00e9dicaments falsifi\u00e9s collaborent pour tenir cette base de donn\u00e9es \u00e0 jour et continuent d\u2019y apporter des am\u00e9liorations. Ils coop\u00e8rent \u00e9galement pour en assurer la promotion et dispensent des formations \u00e0 ses utilisateurs et utilisatrices.<\/p>

Pour plus d\u2019informations, consultez la page web de l\u2019EDQM consacr\u00e9e aux activit\u00e9s antifalsification<\/a>.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t<\/path><\/svg>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\tPage pr\u00e9c\u00e9dente<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t<\/path><\/svg>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\tPage suivante<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"

Quality & use of medicines Qualit\u00e9 et utilisation des m\u00e9dicaments Anti-falsification activities Falsified medical products (medicines and medical devices) pose significant risks, potentially undermining the effectiveness of treatments and even endangering patients\u2019 lives. To combat these risks and protect public health, the EDQM leads comprehensive efforts to foster international dialogue and co-operation, encourage expertise and […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"ocean_front_end_style_editor":"no","ocean_post_layout":"","ocean_both_sidebars_style":"","ocean_both_sidebars_content_width":0,"ocean_both_sidebars_sidebars_width":0,"ocean_sidebar":"","ocean_second_sidebar":"","ocean_disable_margins":"enable","ocean_add_body_class":"","ocean_shortcode_before_top_bar":"","ocean_shortcode_after_top_bar":"","ocean_shortcode_before_header":"","ocean_shortcode_after_header":"","ocean_has_shortcode":"","ocean_shortcode_after_title":"","ocean_shortcode_before_footer_widgets":"","ocean_shortcode_after_footer_widgets":"","ocean_shortcode_before_footer_bottom":"","ocean_shortcode_after_footer_bottom":"","ocean_display_top_bar":"default","ocean_display_header":"default","ocean_header_style":"","ocean_center_header_left_menu":"","ocean_custom_header_template":"","ocean_custom_logo":0,"ocean_custom_retina_logo":0,"ocean_custom_logo_max_width":0,"ocean_custom_logo_tablet_max_width":0,"ocean_custom_logo_mobile_max_width":0,"ocean_custom_logo_max_height":0,"ocean_custom_logo_tablet_max_height":0,"ocean_custom_logo_mobile_max_height":0,"ocean_header_custom_menu":"","ocean_menu_typo_font_family":"","ocean_menu_typo_font_subset":"","ocean_menu_typo_font_size":0,"ocean_menu_typo_font_size_tablet":0,"ocean_menu_typo_font_size_mobile":0,"ocean_menu_typo_font_size_unit":"px","ocean_menu_typo_font_weight":"","ocean_menu_typo_font_weight_tablet":"","ocean_menu_typo_font_weight_mobile":"","ocean_menu_typo_transform":"","ocean_menu_typo_transform_tablet":"","ocean_menu_typo_transform_mobile":"","ocean_menu_typo_line_height":0,"ocean_menu_typo_line_height_tablet":0,"ocean_menu_typo_line_height_mobile":0,"ocean_menu_typo_line_height_unit":"","ocean_menu_typo_spacing":0,"ocean_menu_typo_spacing_tablet":0,"ocean_menu_typo_spacing_mobile":0,"ocean_menu_typo_spacing_unit":"","ocean_menu_link_color":"","ocean_menu_link_color_hover":"","ocean_menu_link_color_active":"","ocean_menu_link_background":"","ocean_menu_link_hover_background":"","ocean_menu_link_active_background":"","ocean_menu_social_links_bg":"","ocean_menu_social_hover_links_bg":"","ocean_menu_social_links_color":"","ocean_menu_social_hover_links_color":"","ocean_disable_title":"default","ocean_disable_heading":"default","ocean_post_title":"","ocean_post_subheading":"","ocean_post_title_style":"","ocean_post_title_background_color":"","ocean_post_title_background":0,"ocean_post_title_bg_image_position":"","ocean_post_title_bg_image_attachment":"","ocean_post_title_bg_image_repeat":"","ocean_post_title_bg_image_size":"","ocean_post_title_height":0,"ocean_post_title_bg_overlay":0.5,"ocean_post_title_bg_overlay_color":"","ocean_disable_breadcrumbs":"default","ocean_breadcrumbs_color":"","ocean_breadcrumbs_separator_color":"","ocean_breadcrumbs_links_color":"","ocean_breadcrumbs_links_hover_color":"","ocean_display_footer_widgets":"default","ocean_display_footer_bottom":"default","ocean_custom_footer_template":"","footnotes":""},"class_list":["post-416","page","type-page","status-publish","hentry","entry"],"yoast_head":"\nAnti-falsification activities | Quality & use of medicines - EDQM<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/annualreport-2025.guerillainteractive.co.uk\/fr\/activites-antifalsification\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Anti-falsification activities | Quality & use of medicines - EDQM\" \/>\n<meta property=\"og:description\" content=\"Quality & use of medicines Qualit\u00e9 et utilisation des m\u00e9dicaments Anti-falsification activities Falsified medical products (medicines and medical devices) pose significant risks, potentially undermining the effectiveness of treatments and even endangering patients\u2019 lives. To combat these risks and protect public health, the EDQM leads comprehensive efforts to foster international dialogue and co-operation, encourage expertise and […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/annualreport-2025.guerillainteractive.co.uk\/fr\/activites-antifalsification\/\" \/>\n<meta property=\"og:site_name\" content=\"EDQM\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-24T13:03:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/annualreport-2025.guerillainteractive.co.uk\/wp-content\/uploads\/2024\/06\/PhEur-11th-Visual-FR-vials-FINAL-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1573\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/annualreport-2025.guerillainteractive.co.uk\\\/anti-falsification-activities\\\/\",\"url\":\"https:\\\/\\\/annualreport-2025.guerillainteractive.co.uk\\\/anti-falsification-activities\\\/\",\"name\":\"Anti-falsification activities | Quality & use of medicines - EDQM\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/annualreport-2025.guerillainteractive.co.uk\\\/en\\\/#website\"},\"datePublished\":\"2024-04-25T12:09:17+00:00\",\"dateModified\":\"2025-07-24T13:03:40+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/annualreport-2025.guerillainteractive.co.uk\\\/anti-falsification-activities\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/annualreport-2025.guerillainteractive.co.uk\\\/anti-falsification-activities\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/annualreport-2025.guerillainteractive.co.uk\\\/anti-falsification-activities\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/annualreport-2025.guerillainteractive.co.uk\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Anti-falsification activities | Quality & use of medicines\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/annualreport-2025.guerillainteractive.co.uk\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/annualreport-2025.guerillainteractive.co.uk\\\/en\\\/\",\"name\":\"EDQM\",\"description\":\"2023 Annual Report\",\"publisher\":{\"@id\":\"https:\\\/\\\/annualreport-2025.guerillainteractive.co.uk\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/annualreport-2025.guerillainteractive.co.uk\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/annualreport-2025.guerillainteractive.co.uk\\\/en\\\/#organization\",\"name\":\"EDQM\",\"url\":\"https:\\\/\\\/annualreport-2025.guerillainteractive.co.uk\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/annualreport-2025.guerillainteractive.co.uk\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/annualreport-2025.guerillainteractive.co.uk\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/cropped-EDQM-Favicon.jpg\",\"contentUrl\":\"https:\\\/\\\/annualreport-2025.guerillainteractive.co.uk\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/cropped-EDQM-Favicon.jpg\",\"width\":512,\"height\":512,\"caption\":\"EDQM\"},\"image\":{\"@id\":\"https:\\\/\\\/annualreport-2025.guerillainteractive.co.uk\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Anti-falsification activities | Quality & use of medicines - EDQM","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/fr\/activites-antifalsification\/","og_locale":"fr_FR","og_type":"article","og_title":"Anti-falsification activities | Quality & use of medicines - EDQM","og_description":"Quality & use of medicines Qualit\u00e9 et utilisation des m\u00e9dicaments Anti-falsification activities Falsified medical products (medicines and medical devices) pose significant risks, potentially undermining the effectiveness of treatments and even endangering patients\u2019 lives. To combat these risks and protect public health, the EDQM leads comprehensive efforts to foster international dialogue and co-operation, encourage expertise and […]","og_url":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/fr\/activites-antifalsification\/","og_site_name":"EDQM","article_modified_time":"2025-07-24T13:03:40+00:00","og_image":[{"width":2560,"height":1573,"url":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/wp-content\/uploads\/2024\/06\/PhEur-11th-Visual-FR-vials-FINAL-scaled.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/anti-falsification-activities\/","url":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/anti-falsification-activities\/","name":"Anti-falsification activities | Quality & use of medicines - EDQM","isPartOf":{"@id":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/en\/#website"},"datePublished":"2024-04-25T12:09:17+00:00","dateModified":"2025-07-24T13:03:40+00:00","breadcrumb":{"@id":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/anti-falsification-activities\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/annualreport-2025.guerillainteractive.co.uk\/anti-falsification-activities\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/anti-falsification-activities\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/"},{"@type":"ListItem","position":2,"name":"Anti-falsification activities | Quality & use of medicines"}]},{"@type":"WebSite","@id":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/en\/#website","url":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/en\/","name":"EDQM","description":"2023 Annual Report","publisher":{"@id":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/en\/#organization","name":"EDQM","url":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/en\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/en\/#\/schema\/logo\/image\/","url":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/wp-content\/uploads\/2024\/04\/cropped-EDQM-Favicon.jpg","contentUrl":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/wp-content\/uploads\/2024\/04\/cropped-EDQM-Favicon.jpg","width":512,"height":512,"caption":"EDQM"},"image":{"@id":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/en\/#\/schema\/logo\/image\/"}}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/fr\/wp-json\/wp\/v2\/pages\/416","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/fr\/wp-json\/wp\/v2\/comments?post=416"}],"version-history":[{"count":53,"href":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/fr\/wp-json\/wp\/v2\/pages\/416\/revisions"}],"predecessor-version":[{"id":5015,"href":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/fr\/wp-json\/wp\/v2\/pages\/416\/revisions\/5015"}],"wp:attachment":[{"href":"https:\/\/annualreport-2025.guerillainteractive.co.uk\/fr\/wp-json\/wp\/v2\/media?parent=416"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}